EverSource Wealth Advisors
CNTB icon

EverSource Wealth Advisors’s Connect Biopharma Holdings CNTB Stock Holding History

EverSource Wealth Advisors’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,247
Closed -$3.27K – 4420
2026
Q1 		$3.27K Sell
1,247
-41
-3% -$107 ﹤0.01% 3464
2025
Q4 		$3.63K Sell
1,288
-294
-19% -$627 ﹤0.01% 3248
2025
Q3 		$2.39K Hold
1,582
– – ﹤0.01% 3462
2025
Q2 		$1.55K Buy
+1,582
New +$1.26K ﹤0.01% 3587

Other funds holding CNTB

Ikarian Capital
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Boothbay Fund Management
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ADAR1 Capital Management
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
Silverarc Capital Management
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.65% 1-Year Est. Return
Richmond Brothers
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

EverSource Wealth Advisors's CNTB Position: Q2 2026 in Review

EverSource Wealth Advisors sold out of Connect Biopharma Holdings (CNTB) in Q2 2026, closing a stake of 1,247 shares — an estimated $3.27K sold.

EverSource Wealth Advisors first reported a position in CNTB in Q2 2025 and held it in 4 quarters. The position peaked at $3.63K in Q4 2025. 57 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • EverSource Wealth Advisors reported no remaining Connect Biopharma Holdings position as of Q2 2026 after selling out during the quarter.
  • EverSource Wealth Advisors sold 1,247 Connect Biopharma Holdings shares in Q2 2026, an estimated $3.27K.
  • EverSource Wealth Advisors first reported a position in Connect Biopharma Holdings in Q2 2025 and held it in 4 quarters.
  • EverSource Wealth Advisors's Connect Biopharma Holdings position peaked at $3.63K in Q4 2025.
  • 57 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.